MENU
TMDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TransMedics Group (TMDX) Earnings Date & Reports

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states... Show more

A.I. Advisor
published Earnings

TMDX is expected to report earnings to fall 40.65% to 39 cents per share on March 04

TransMedics Group TMDX Stock Earnings Reports
Q4'25
Est.
$0.39
Q3'25
Beat
by $0.30
Q2'25
Beat
by $0.47
Q1'25
Beat
by $0.44
Q4'24
Beat
by $0.03
The last earnings report on October 29 showed earnings per share of 66 cents, beating the estimate of 36 cents. With 243.94K shares outstanding, the current market capitalization sits at 4.07B.
View a ticker or compare two or three
TMDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TMDX showed earnings on October 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of a proprietary system for preserving human organs for transplant

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
200 Minuteman Road
Phone
+1 978 552-0900
Employees
584
Web
https://www.transmedics.com